Cork, M.J. et al. 2024. Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator’s Global Assessment: A Post Hoc Analysis of a Phase 3 Trial. Acta Dermato-Venereologica. 104, (Feb. 2024), adv13467. DOI:https://doi.org/10.2340/actadv.v104.13467.